FCGR2B and rheumatoid arthritis: Significantly higher frequencies of cells presenting CD32 from whole blood were seen in patients with AOSD (80.3% ± 11.4%) than in patients with RA (57.4% ± 16.9%, p < 0.001) or HC (50.6% ± 14%, p < 0.001; Figure 2B).